default author photo

Ning Ding

Peking University - Key Laboratory of Carcinogenesis and Translational Research

No. 38 Xueyuan Road

Haidian District

Beijing, Beijing 100871

China

  • Peking University - Key Laboratory of Carcinogenesis and Translational Research

SCHOLARLY PAPERS

2

DOWNLOADS

154

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Ibrutinib Combined With Low-Dose HDAC Inhibitor Chidamide Synergistically Enhances the Anti-Tumor Effect in B-Cell Lymphoma

Number of pages: 20 Posted: 31 Jan 2022
Hui Yu, Lan Mi, Weimin Zhang, Yingying Ye, Miaomiao Li, Dingyao Hu, Jiaowu Cao, Dedao Wang, Xiaogan Wang, Ning Ding, Yuqin Song and Zhu Jun
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research and Peking University - Key Laboratory of Carcinogenesis and Translational Research
Downloads 99 (704,534)

Abstract:

Loading...

BTK inhibitor, HDAC inhibitor, B-cell lymphoma, Drug combination, Tumor microenvironment

2.

Targeted Degradation of Programmed Death Ligand 1 with a Bispecific Aptamer-Based Lysosome-Targeting Chimera

Number of pages: 20 Posted: 26 Jul 2025
Yuyang Li, Yuyang Li, Jingrui Li, Renshuai Zhang, Ruixin Ge, Wei Pan, Jie Chen, Ning Ding, Min Liu and Songbo Xie
affiliation not provided to SSRN, affiliation not provided to SSRN, Shandong University of Technology, Shandong Normal University, affiliation not provided to SSRN, Shandong Normal University, Shandong University of Technology, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Shandong Normal University and affiliation not provided to SSRN
Downloads 55 (1,020,567)

Abstract:

Loading...

cancer immunotherapy, programmed death ligand 1, targeted protein degradation, Aptamer, lysosome-targeting chimera